Global Markets for Vaccine Technologies

1
Global Markets for Vaccine Technologies
2
Summary

• The global market for vaccine technologies
  reached 33.3 billion in 2016 and should reach
  45.2 billion by 2021, growing at a compound
  annual growth rate (CAGR) of 6.3 from 2016 to
  2021.
• Report Includes
• -An overview of the global market for human and
  animal (veterinary) vaccines
• -Analyses of global market trends, with data from
  2015, estimates for 2016, and projections of
  compound annual growth rates (CAGRs) through 2021
• -A review of vaccine technology and its
  challenges, innovations, opportunities and
  regulatory hurdles
• -Evaluations of market sizes and developments for
  vaccine classes (prophylactic and therapeutic),
  vaccine types (inactivated, conjugate,
  attenuated, recombinant vector, subunit, toxoid,
  combination and dendritic cells), vaccine
  end-users (humans and animals) and disease
  indications (infectious, cancer and allergy)

www.BharatBook.com
3
(No Transcript)
4
INTRODUCTION

• STUDY OBJECTIVES
• Vaccines are an important part of the global
  healthcare market. Human vaccines are available
  for a wide range of diseases such as polio
  measles, mumps and rubella (MMR) tetanus
  diphtheria hepatitis and influenza. Animal
  health vaccines offer applications such as
  antibiotics, parasiticides and medicinal feed
  additives and vaccines for both livestock and
  companion animals.
• The outlook of the market, the setbacks and the
  needs of the market are discussed in this report.
  The classifications and usage of these products
  are also described in this report.
• A detailed analysis of the vaccine technology
  industrys structure has been conducted. The
  revenues are broken down by region, while sales
  figures are estimated for the five-year period
  from 2016 through 2021. The applications of these
  vaccines are discussed separately in the report.
  The report also covers significant patents and
  their allotments in each category.

www.BharatBook.com
5

• REASONS FOR DOING THIS STUDY
• Vaccines are one of the most cost-effective ways
  to reduce the global disease load. The global
  rise in infectious and noninfectious diseases,
  the growing population, advancements in science
  and technology, as well as the resurgence of
  vaccine preventable diseases and the emergence of
  new pandemics and immunization programs run in
  developing geographies are influencing the global
  vaccines market. In humans, vaccines are used to
  prevent or treat various human diseases. Based on
  whether they prevent diseases or treat
  pre-existing ones, vaccines can be divided
  broadly into prophylactic and therapeutic
  vaccines. In contrast, animal vaccines are
  categorized for food-producing animals (porcine,
  bovine, poultry, ovine, fish) and for companion
  animals (canine, feline and equine vaccines) and
  other animal vaccines (rabbit, etc.).
• Research and development (RD spending, along
  with increasing competition and new technologies
  are giving direction to the market. These
  advancements, new product launches and changing
  lifestyles are influencing future market growth.
  This study looks at almost all the systems
  affected by these factors.
• Acquisition strategies and collaborations by
  companies are also covered in this report. In
  addition, this study also discusses the strengths
  and weaknesses of each strategy type in light of
  the new technologies, growing competition and
  changing customer needs.

www.BharatBook.com
6

• The market also has been analyzed based on the
  application of these vaccines. Categories
  considered in this report are meningococcal/pneumo
  coccal vaccines, influenza vaccines, pediatric
  polio/pertussis/Hib vaccines, adult/adolescent
  booster vaccines, vaccines for travel-related and
  other endemic diseases, HPV vaccines, rotavirus
  vaccines and other (minor) vaccines.
• CONTRIBUTIONS OF THE STUDY AND FOR WHOM
• This study contributes to the areas of market
  growth among vaccine manufacturers and users.
  Genomic research centers, academic institutions,
  government and private laboratories, various
  hospital settings as well as pharmaceutical,
  diagnostic and biotechnology companies and
  physicians will find this study to be of interest.

www.BharatBook.com
7
SCOPE OF THE STUDY

• The scope of this study entails the current
  market for human and animal vaccines. The report
  also includes regulatory aspects, current and
  developing technologies, market projections and
  market share. An analysis of patents, clinical
  trials, innovations and opportunities, as well as
  the latest trends is also discussed.
• Sales data for the global and regional markets
  were corroborated for the present and forecasted
  values based on statistical analysis. Regions are
  categorized into the United States, Europe and
  the emerging markets, which include India, China,
  Japan, South Korea, Taiwan, Canada, Africa,
  Australia and New Zealand. The application of
  vaccines in various diseases is discussed from
  both a commercial and RD perspective.

www.BharatBook.com
8
METHODOLOGY

• Both primary and secondary research methodologies
  were used in preparing this study. It conducted a
  comprehensive literature search, which included
  technical newsletters and journals, and many
  other sources. Data were collected through
  interviews and correspondence with manufacturers
  and users of vaccine technology products.
  Projections were based on estimates such as the
  current number of end users, potential end users,
  mergers and acquisitions, and market trends.

www.BharatBook.com
9
INFORMATION SOURCES

• Many companies were surveyed to obtain data for
  this study. Included were manufacturers and end
  users of vaccine technology. Data were gathered
  from various industry sources. In addition,
  interviewed industry officials, consulted
  newsletters, company literature, product
  literature and various technical articles,
  journals, indexes and abstracts. Exhaustive
  investigations of databases by key terminology
  were completed. In addition, data were compiled
  from current financial, trade and government
  sources.

www.BharatBook.com
10
Table of Contents

• Introduction
• Executive Summary
• Overview
• Regulatory Aspects
• New Developments
• Market Analysis Of Human Vaccines
• Market Analysis Of Animal Vaccines
• Industry Structure
• Market By Application For Human Vaccines
• Patent Analysis
• Current Situation
• Company Profiles
• Appendix

www.BharatBook.com
11
Full Reports
Global Markets for Vaccine Technologies
Bharat Book Bureau Tel [phone] /
27810773 Email poonam_at_bharatbook.com Website
www.bharatbook.com FaceBook BharatBook3B Twitter
ResearchBook LinkedIn Bharat Book Bureau
12
Thank You